Swissmedic Rolls Out First Changes to Drug Authorization Process

International Pharmaceutical Regulatory Monitor
A A
Swissmedic is revising its drug approval process to streamline authorizations for certain products. The overhaul will take place in several phases, beginning in early 2018. The first revisions will address pediatric drug dosage recommendations.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor